BioMarin Pharmaceutical Inc. – Special Call – Seeking Alpha
By Dr. Matthew Watson
BioMarin Pharmaceutical Inc. - Special Call Seeking Alpha On the call today is J.J. Bienaimé, BioMarin's CEO; Hank Fuchs, Chief Medical Officer; our special guest speaker, Dr. Barry Byrne, Professor of Pediatrics and Molecular Genetics & Microbiology and Director at the University of Florida Powell Center and ... BioMarin to Advance BMN-701 for Pompe Disease to Next Phase of DevelopmentGlobeNewswire (press release) |
Uncategorized
Comments Off on BioMarin Pharmaceutical Inc. – Special Call – Seeking Alpha |
March 24th, 2013
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research